Portfolio Companies
Hydrograph Clean Power
Properties of Pure Graphene
A private company based in Takoma Park, Maryland The company has in excess of 200 patents filed for and. or granted. The FDA recently approved USMI’s cutting-edge surgical device for cancer treatment, and awarded the company de novo status.
USMI: The Future of Surgery
USMI is dedicated to innovation in the fields of electrosurgery and plasma technology for the advancement of patient outcomes, the eradication of cancer and the improvement of human lives. Our Core Values of Innovation, Diversity, and Community are key to our pursuit of this mission and to our ongoing success.
INNOVATION
Leveraging the insights of our CEO and Co-Founder, in his capacity as both a transplant surgeon and inventor, we constantly look to the needs of our patients and doctors to understand the areas of greatest urgency for the development of new medical tools. This understanding drives the development of our pipeline of surgical devices as we seek to push the boundary of new technologies in the fields of electrosurgery, plasma surgery, and minimally invasive surgical and endoscopic procedures. For this reason, a large portion of our operation is dedicated to research and development of new patents and products. Through our sister company, Plasma Medicine Life Science, we are working to develop our ground-breaking Helios™ Cold Plasma product line for the eradication of cancer.
DIVERSITY
USMI is the first major US biomedical devices company to be majority owned and operated by women. We believe that our diverse cultural, academic and professional backgrounds, as well as our commitment to diversity of thought, are keys to our ability to successfully provide market-leading technologies and cutting-edge resources for both the public and the medical community.